Correlation Between InMode and CONMED
Can any of the company-specific risk be diversified away by investing in both InMode and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMode and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMode and CONMED, you can compare the effects of market volatilities on InMode and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMode with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMode and CONMED.
Diversification Opportunities for InMode and CONMED
Weak diversification
The 3 months correlation between InMode and CONMED is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding InMode and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and InMode is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMode are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of InMode i.e., InMode and CONMED go up and down completely randomly.
Pair Corralation between InMode and CONMED
Given the investment horizon of 90 days InMode is expected to generate 1.3 times more return on investment than CONMED. However, InMode is 1.3 times more volatile than CONMED. It trades about -0.03 of its potential returns per unit of risk. CONMED is currently generating about -0.05 per unit of risk. If you would invest 3,411 in InMode on August 31, 2024 and sell it today you would lose (1,458) from holding InMode or give up 42.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
InMode vs. CONMED
Performance |
Timeline |
InMode |
CONMED |
InMode and CONMED Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with InMode and CONMED
The main advantage of trading using opposite InMode and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMode position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.InMode vs. TransMedics Group | InMode vs. Inspire Medical Systems | InMode vs. Inari Medical | InMode vs. Insulet |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |